Antibiotic treatment forStenotrophomonas maltophiliain people with cystic fibrosis-Reference-Cited by-同舟云学术

Antibiotic treatment forStenotrophomonas maltophiliain people with cystic fibrosis

Published:2016-07-14 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Amin Reshma¹,Waters Valerie²

Affiliation:

1. The Hospital for Sick Children; Department of Pediatric Respirology; 555 University Avenue Toronto ON Canada M5G 1X8

2. Hospital for Sick Children; Department of Pediatrics, Division of Infectious Diseases; 555 University Avenue Toronto ON Canada M5G 1X8

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD009249.pub4/fullpdf

Reference49 articles.

1. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomized, double-blind, controlled clinical trial;Aaron;Lancet,2005

2. Are morning doses of intravenous tobramycin less nephrotoxic than evening? Evidence from urinary biomarkers in the critic study [abstract];Prayle;Pediatric Pulmonology,2013

3. A clinically-embedded trial to evaluate the efficacy of interventions for pre-pseudomonal pathogens [abstract];Singh;Pediatric Pulmonology,2013

4. A phase 1 safety, tolerability and pharmacokinetic (PK) study of MP-376 (levofloxacin solution for inhalation) in stable cystic fibrosis (CF) patients [abstract];Geller;Pediatric Pulmonology,2008

5. Single-dose pharmacokinetics of aerosol MP-376 (levofloxacin solution for inhalation) in cystic fibrosis patients: PK-PD implications [abstract];Griffith;Journal of Cystic Fibrosis,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-regulation of Thermosensor Pathogenic Factors by C-di-GMP-Related Two-Component Systems and a cAMP Receptor-like Protein (Clp) in Stenotrophomonas maltophilia;Foods;2024-04-15

2. A guide to Stenotrophomonas maltophilia virulence capabilities, as we currently understand them;Frontiers in Cellular and Infection Microbiology;2024-01-11

3. Airway microbiota correlated with pulmonary exacerbation in primary ciliary dyskinesia patients;Microbiology Spectrum;2023-12-12

4. Myxinidin-Derived Peptide against Biofilms Caused by Cystic Fibrosis Emerging Pathogens;International Journal of Molecular Sciences;2023-02-04

5. Antibiotherapy in Children with Cystic Fibrosis—An Extensive Review;Children;2022-08-20